anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (FITC)
|Synonyms||BAFF-R; BAFF Receptor; BR3; BlySR3; Tumor Necrosis Factor Receptor Superfamily Member 13C; TNFRSF13C|
|Product Type||Monoclonal Antibody|
|Immunogen/Antigen||Recombinant human CD268.|
|Formulation||50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative).|
|Isotype Negative Control|
|Other Product Data||
Click here for Original Manufacturer Product Datasheet
|Declaration||Manufactured by Ancell Corporation.|
|Shipping and Handling|
|Short Term Storage||+4°C|
|Long Term Storage||+4°C|
Avoid freeze/thaw cycles.
Protect from light.
|Use/Stability||Stable for at least 1 year after receipt when stored at +4°C.|
|Product Specification Sheet|
Three receptors for BAFF were recently identified and designated TACI, BCMA and BAFF-R. BAFF-R signaling is essential for B cell development, survival and humoral immune responses.